Quidelortho (QDEL) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 28 2026 to Jun 29 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quidelortho Corp  (NASDAQ: QDEL)


Quidelortho's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Quidelortho's ROA in the second quarter of 2026?
Quidelortho Corp had a negative return on assets (ROA) of -18.53%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

However, within the Healthcare sector 350 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 28 2026 quarter, so far to 3467, from total ROA ranking in the first quarter of 2026 at 4019.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 28 2026)
II. Quarter		 (Mar 29 2026)
I. Quarter		 (Dec 28 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Total Assets Change -8.16 % -10.63 % -5.16 % -16.43 % -4.11 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -1,048 -1,211 -1,132 -1,180 -466
Return On Assets (TTM) -18.53 % -20.93 % -19.01 % -19.56 % -7.4 %
QDEL's Total Ranking # 3467 # 4019 # 3524 # 3152 # 3094
Total Assets (TTM) in million 5,715 5,629 5,769 5,519 6,223
Seq. Total Assets Change 1.54 % -2.44 % 4.54 % -11.32 % -1.19 %
Seq. Net Income Change - - - - -

QDEL's 5 Years Annual ROA >> Back to QDEL Management Effectiveness >> Compare QDEL ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 5
Sector # 351
Overall # 3391

Return On Assets Statistics
High Average Low
64.05 %
4.87 %
-30.84 %
(Dec 31 2020)   (Dec 29 2024)



  News about Quidelortho Corp Return on Assets ROA

A New Look at QuidelOrtho Corporation (QDEL) Stocks Hidden Strategies

QuidelOrtho Corporation Reports Strong Second Quarter 2024 Financial Results Amidst Market ChallengesQuidelOrtho Corporation (Nasdaq: QDEL), a global provider of innovative in vitro diagnostic technologies, has announced its second quarter 2024 financial results, defying market expectations amidst ongoing challenges. The company has demonstrated resilience, maintaining its position as a leader in point-of-care settings and clinical labs.Despite market volatility, QuidelOrtho has consistently delivered innovative solutions that cater to the evolving needs of the healthcare industry. The company s commitment to developing cutting-edge diagnostic technologies has enabled it to thrive even in uncertain times. QuidelOrtho s robust portfolio of products has been widely embraced by medical professionals, consolidating the company s position as a trusted partner in the field of diagnostics.



Financial Statements
Quidelortho's Assets $ 5,715 million QDEL's Balance sheet
Quidelortho's Income $ -93 million Quarterly QDEL's Income Statement
QDEL's Income by Division See QDEL's Income by Division



Annual Return On Assets (Dec 28 2025)
FY 2025		 (Dec 29 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Jan 01 2023)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -7.79 % -25.25 % -3.33 % 278.97 % 32.21 %
Total Assets in million 5,769 6,257 8,371 8,660 2,285
Y / Y Net Income Change - - - -22.08 % -13.09 %
Net Income in million -1,132 -2,052 -10 549 704
Annual Return On Assets -19.62 % -32.8 % -0.12 % 6.34 % 30.82 %

QDEL's 5 Years Annual ROA >> Back to QDEL Management Effectiveness >> Compare QDEL ROA to its Competitors



More Return On Assets Ratios
QDEL's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QDEL's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for QDEL's Competitors
Subscribers only: Roa for Quidelortho's Suppliers
Subscribers only: Return On Assets for QDEL's Customers

You may also want to know
QDEL's Roi QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons
QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 28 2026, within Healthcare Sector ROA

Date modified: 2026-09-26T07:41:41+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.